CVV RSI Chart
Last 7 days
-11.5%
Last 30 days
4.0%
Trailing 12 Months
-54.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 7.2M | 12.8M | 18.5M | 24.1M |
2022 | 17.7M | 19.5M | 23.3M | 1.5M |
2021 | 14.2M | 14.6M | 14.9M | 16.4M |
2020 | 22.2M | 21.0M | 19.3M | 16.9M |
2019 | 18.6M | 17.1M | 18.8M | 19.6M |
2018 | 40.6M | 36.2M | 29.4M | 24.3M |
2017 | 25.6M | 32.7M | 38.6M | 41.1M |
2016 | 34.3M | 27.6M | 21.8M | 21.0M |
2015 | 33.3M | 37.6M | 39.4M | 39.0M |
2014 | 18.8M | 20.1M | 24.2M | 28.0M |
2013 | 18.5M | 16.2M | 16.2M | 17.9M |
2012 | 31.9M | 31.5M | 27.4M | 22.2M |
2011 | 19.9M | 23.6M | 27.3M | 31.0M |
2010 | 0 | 0 | 0 | 16.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 02, 2024 | africk andrew | bought | 234,771 | 5.07 | 46,306 | - |
Apr 01, 2024 | africk andrew | bought | 849,390 | 4.96 | 171,248 | - |
Dec 01, 2023 | africk andrew | bought | 255,974 | 4.78 | 53,551 | - |
Nov 30, 2023 | africk andrew | bought | 192,392 | 4.51 | 42,659 | - |
Nov 16, 2023 | africk andrew | bought | 347,820 | 5.61 | 62,000 | - |
Nov 15, 2023 | africk andrew | bought | 472,962 | 5.51 | 85,837 | - |
Aug 22, 2023 | africk andrew | bought | 85,365 | 7.00 | 12,195 | - |
Aug 21, 2023 | africk andrew | bought | 207,506 | 6.34283 | 32,715 | - |
Jul 13, 2023 | brill dr robert m | acquired | - | - | 8,746 | - |
Jul 13, 2023 | waldman lawrence | acquired | - | - | 8,746 | - |
Which funds bought or sold CVV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 10.58 | -494,465 | 1,383,180 | -% |
Feb 14, 2024 | OBERWEIS ASSET MANAGEMENT INC/ | sold off | -100 | -684,971 | - | -% |
Feb 14, 2024 | STATE STREET CORP | unchanged | - | -44,881 | 82,159 | -% |
Feb 14, 2024 | AMERIPRISE FINANCIAL INC | reduced | -13.2 | -374,882 | 479,786 | -% |
Feb 14, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 13.00 | 13.00 | -% |
Feb 14, 2024 | Coppell Advisory Solutions LLC | reduced | -52.94 | -116 | 71.00 | -% |
Feb 14, 2024 | TWO SIGMA ADVISERS, LP | sold off | -100 | -77,807 | - | -% |
Feb 14, 2024 | Royal Bank of Canada | added | 130 | - | 1,000 | -% |
Feb 14, 2024 | CITADEL ADVISORS LLC | new | - | 89,296 | 89,296 | -% |
Feb 13, 2024 | Tower Research Capital LLC (TRC) | added | 53.19 | 104 | 5,205 | -% |
Unveiling CVD Equipment Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to CVD Equipment Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
CAT | 182.8B | 67.1B | 17.69 | 2.73 | ||||
GE | 166.4B | 68.0B | 17.56 | 2.45 | ||||
CMI | 41.3B | 34.1B | 49.21 | 1.21 | ||||
AME | 41.0B | 6.6B | 31.19 | 6.21 | ||||
ACM | 12.7B | 14.9B | 205.12 | 0.85 | ||||
MID-CAP | ||||||||
APG | 9.1B | 6.9B | 59.68 | 1.32 | ||||
FLR | 6.7B | 15.5B | 48.22 | 0.43 | ||||
FLS | 6.0B | 4.3B | 32.06 | 1.39 | ||||
ACA | 3.7B | 2.3B | 23.13 | 1.6 | ||||
ALG | 2.5B | 1.7B | 18.11 | 1.46 | ||||
SMALL-CAP | ||||||||
AMRC | 967.7M | 1.4B | 15.49 | 0.7 | ||||
NKLA | 881.5M | 35.8M | -0.91 | 24.6 | ||||
AGX | 807.6M | 573.3M | 24.96 | 1.41 | ||||
AMSC | 361.2M | 135.4M | -22.02 | 2.67 | ||||
ADES | 238.3M | 99.2M | -19.46 | 2.4 |
CVD Equipment Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -34.1% | 4,111 | 6,234 | 5,069 | 8,695 | 8,407 | 8,119 | 5,809 | 4,656 | 4,717 | 4,329 | 4,034 | 3,366 | 3,172 | 3,993 | 3,719 | 6,036 | 5,551 | 5,705 | 4,918 | 3,469 | 4,717 |
Cost Of Revenue | -3.8% | 4,460 | 4,636 | 3,681 | 6,261 | 5,234 | 5,699 | 4,368 | 3,886 | 3,945 | 3,466 | 3,037 | 2,922 | 3,262 | 3,557 | 3,117 | 4,101 | 4,259 | 4,305 | 4,425 | 3,856 | 4,360 |
Gross Profit | -121.8% | -348 | 1,598 | 1,388 | 2,434 | 1,998 | 2,420 | 1,441 | 770 | 772 | 863 | 997 | 444 | -90.42 | 436 | 602 | 1,936 | 1,292 | 1,400 | 493 | -387 | 357 |
Operating Expenses | -18.0% | 2,123 | 2,588 | 2,620 | 2,621 | 2,223 | 2,298 | 2,188 | 1,740 | 1,812 | 1,786 | 2,080 | 2,063 | 5,317 | 1,828 | 1,734 | 1,827 | 1,919 | 1,648 | 2,036 | 2,177 | 2,289 |
S&GA Expenses | -19.1% | 351 | 434 | 428 | 419 | 321 | 290 | 332 | 273 | 261 | 238 | 229 | 136 | 141 | 142 | 131 | 166 | 218 | 176 | 227 | 277 | 376 |
R&D Expenses | 3.8% | 731 | 704 | 559 | 602 | 509 | 518 | 569 | 310 | 597 | 446 | 431 | 311 | 72.00 | 90.00 | 96.00 | 114 | 144 | 113 | 177 | 164 | 141 |
EBITDA Margin | -791.3% | -0.14* | 0.02* | 0.05* | 0.05* | 0.03* | -0.10* | 0.19* | 0.35* | 0.35* | 0.13* | -0.35* | -0.53* | -0.34* | - | - | - | - | - | - | - | - |
Interest Expenses | -16.7% | 5.00 | 6.00 | 6.00 | 6.00 | 920.50* | 159* | - | 9.00 | 11.00 | 36.00 | 107 | 107 | 109 | 104 | 114 | 116 | 118 | 124 | 126 | 115 | 108 |
Income Taxes | -4900.0% | -25.00 | -500* | 10.00 | 2.00 | 3.00 | 65* | 1.00 | - | -391* | 27.00 | 1.00 | - | 2.00 | - | 1.00 | -1,530 | 2,106 | -1.00 | -234 | -456 | -40.64 |
Earnings Before Taxes | -205.4% | -2,299 | -753 | -1,103 | -38.00 | 1,552 | 63.00 | -838 | -997 | -1,191 | 6,001 | 1,471 | -1,505 | -5,304 | -1,292 | -1,133 | 128 | -514 | -139 | -1,627 | -2,632 | -1,966 |
EBT Margin | -1284.9% | -0.17* | -0.01* | 0.02* | 0.02* | -0.01* | -0.13* | 0.15* | 0.30* | 0.29* | 0.04* | -0.46* | -0.65* | -0.45* | - | - | - | - | - | - | - | - |
Net Income | -202.0% | -2,274 | -753 | -1,113 | -40.00 | 1,549 | 63.00 | -839 | -997 | -1,191 | 5,973 | 1,470 | -1,505 | -5,307 | -1,291 | -1,134 | 1,658 | -2,619 | -138 | -1,392 | -2,176 | -1,926 |
Net Income Margin | -1222.4% | -0.17* | -0.01* | 0.02* | 0.02* | -0.01* | -0.13* | 0.15* | 0.30* | 0.29* | 0.04* | -0.46* | -0.65* | -0.36* | - | - | - | - | - | - | - | - |
Free Cashflow | -135.6% | -240 | 674 | 2,361 | -3,418 | 2,495 | -277 | -1,092 | -1,597 | -720 | -1,818 | -370 | -1,598 | -318 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -5.9% | 35,025 | 37,227 | 36,783 | 34,784 | 37,912 | 33,602 | 34,116 | 32,007 | 35,524 | 35,958 | 38,920 | 39,206 | 40,936 | 46,166 | 48,325 | 48,794 | 46,723 | 49,534 | 49,534 | 50,628 | 51,836 |
Current Assets | -8.3% | 22,841 | 24,903 | 24,362 | 20,554 | 23,658 | 20,573 | 21,566 | 19,609 | 23,070 | 23,356 | 26,256 | 26,460 | 11,790 | 13,430 | 15,565 | 16,142 | 14,166 | 14,480 | 14,694 | 16,962 | 19,447 |
Cash Equivalents | -1.8% | 14,025 | 14,285 | 13,000 | 11,000 | 14,365 | 11,876 | 12,159 | 13,300 | 16,651 | 17,400 | 5,388 | 5,929 | 7,699 | 8,187 | 9,375 | 7,400 | 8,664 | 6,739 | 8,581 | 11,253 | 11,439 |
Inventory | 3.8% | 4,454 | 4,290 | 4,150 | 2,801 | 2,538 | 2,134 | 2,050 | 1,738 | 1,225 | 1,466 | 1,297 | 1,340 | 1,124 | 1,445 | 1,547 | 1,691 | 1,710 | 1,769 | 1,883 | 1,745 | 1,862 |
Net PPE | -0.3% | 12,166 | 12,207 | - | - | 12,596 | 12,814 | - | - | 12,261 | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | -2.1% | 8,822 | 9,011 | 8,064 | 5,217 | 8,513 | 5,880 | 6,575 | 3,719 | 6,336 | 5,676 | 14,717 | 16,535 | 16,810 | 16,776 | 17,702 | 17,105 | 16,765 | 16,373 | 16,116 | 16,214 | 16,122 |
Current Liabilities | -1.9% | 8,554 | 8,723 | 7,755 | 4,888 | 8,164 | 5,524 | 6,575 | 3,719 | 6,336 | 5,676 | 14,717 | 14,119 | 3,704 | 3,491 | 4,249 | 5,897 | 5,388 | 4,825 | 4,400 | 4,330 | 4,071 |
Long Term Debt | -6.9% | 268 | 288 | 309 | 329 | 349 | 356 | - | - | - | - | - | 2,416 | 13,106 | 13,285 | 13,453 | 11,208 | 11,377 | 11,548 | 11,716 | 11,884 | 12,052 |
LT Debt, Current | 1.3% | 81.00 | 80.00 | - | - | 77.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | 865 | 861 | 858 |
LT Debt, Non Current | -6.9% | 268 | 288 | 309 | 329 | 349 | 356 | - | - | - | - | - | 2,416 | 13,106 | 13,285 | 13,453 | 11,208 | 11,377 | 11,548 | 11,716 | 11,884 | 12,052 |
Shareholder's Equity | -7.1% | 26,203 | 28,216 | 28,719 | 29,567 | 29,399 | 27,722 | 27,540 | 28,287 | 29,188 | 30,282 | 24,203 | 22,670 | 24,126 | 29,390 | 30,623 | 31,689 | 29,958 | 32,482 | 32,521 | 33,735 | 35,713 |
Retained Earnings | -795.1% | -2,560 | -286 | 467 | 1,580 | 1,620 | 70.00 | 7.00 | 846 | 1,844 | 3,035 | -2,938 | -4,408 | -2,902 | 2,404 | 3,696 | 4,831 | 3,172 | 6,471 | 6,609 | 8,002 | 9,500 |
Additional Paid-In Capital | 0.9% | 28,695 | 28,434 | 28,185 | 27,920 | 27,712 | 27,584 | 27,466 | 27,374 | 27,277 | 27,180 | 27,074 | 27,012 | 26,962 | 26,919 | 26,861 | 26,792 | 26,720 | 26,624 | 26,526 | 26,347 | 26,148 |
Accumulated Depreciation | - | 10,555 | - | - | - | 9,976 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 0.1% | 6,825 | 6,821 | 6,779 | 6,778 | 6,761 | - | 6,728,938 | 6,725,042 | - | 6,683 | 6,682 | 6,680 | 6,679 | - | - | - | - | - | - | - | - |
Float | - | - | - | 48,002 | - | - | - | 19,376 | - | - | - | 24,513 | - | - | - | 20,045 | - | - | - | 19,741 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -117.2% | -130 | 757 | 2,439 | -3,272 | 2,522 | -99.00 | -809 | -1,420 | -697 | -1,724 | -279 | -1,571 | 56.00 | -678 | 165 | -675 | 2,664 | -996 | -1,513 | 417 | -2,213 |
Share Based Compensation | 4.4% | 261 | 250 | 262 | 135 | 128 | 118 | 92.00 | 97.00 | 97.00 | 105 | 62.00 | 50.00 | 43.00 | 59.00 | 69.00 | 73.00 | 96.00 | 99.00 | 179 | 199 | 236 |
Cashflow From Investing | -121.4% | -110 | 514 | -391 | -146 | -27.00 | -184 | -302 | -195 | -22.56 | 22,981 | -91.73 | -26.74 | -374 | -341 | -438 | -422 | -572 | -681 | -995 | -438 | -279 |
Cashflow From Financing | -5.3% | -20.00 | -19.00 | -16.00 | 54.00 | -6.00 | - | - | -1,766 | -74.75 | -9,198 | -170 | -171 | -169 | -167 | 2,249 | -166 | -165 | -164 | -163 | -164 | -259 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |||||||
Income Statement [Abstract] | ||||||||
Revenue | $ 24,109 | $ 25,813 | ||||||
Cost of revenue | 19,038 | 19,186 | ||||||
Gross profit | 5,071 | 6,627 | ||||||
Operating expenses: | ||||||||
Research and development | 2,596 | 1,906 | ||||||
Selling | 1,632 | 1,216 | ||||||
General and administrative | 5,451 | 5,328 | ||||||
Loss on disposition of Tantaline | 162 | |||||||
Impairment charge | 111 | |||||||
Total operating expenses | 9,952 | 8,450 | ||||||
Operating loss | (4,881) | [1] | (1,823) | |||||
Other income (expense): | ||||||||
Interest income | 577 | 162 | ||||||
Interest expenses | (23) | (8) | ||||||
Employee retention credits | 1,529 | |||||||
Foreign exchange income (loss) | 42 | (95) | ||||||
Other income | 91 | 15 | ||||||
Total other income, net | 687 | 1,603 | ||||||
Loss before income tax | (4,194) | [1] | (220) | [2] | ||||
Income tax (benefit) expense | (14) | 4 | ||||||
Net loss | $ (4,180) | $ (224) | ||||||
Loss per common share: | ||||||||
Basic | $ (0.62) | $ (0.03) | ||||||
Diluted | $ (0.62) | $ (0.03) | ||||||
Weighted average number of shares: | ||||||||
Basic | 6,788 | 6,734 | ||||||
Diluted | 6,788 | 6,734 | ||||||
|
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 14,025 | $ 14,365 |
Accounts receivable, net | 1,906 | 3,788 |
Contract assets | 1,604 | 2,170 |
Inventories, net | 4,454 | 2,538 |
Other current assets | 852 | 797 |
Total current assets | 22,841 | 23,658 |
Employee retention credit receivable | 1,529 | |
Property, plant and equipment, net | 12,166 | 12,596 |
Intangible assets, net | 9 | 119 |
Other assets | 9 | 10 |
Total assets | 35,025 | 37,912 |
Current liabilities: | ||
Accounts payable | 1,203 | 1,454 |
Accrued expenses | 1,765 | 2,591 |
Current maturities of long-term debt | 81 | 77 |
Deposits from purchasers of MesoScribe assets – note 15 | 597 | |
Contract liabilities | 4,908 | 4,042 |
Total current liabilities | 8,554 | 8,164 |
Long-term debt, net of current portion | 268 | 349 |
Total liabilities | 8,822 | 8,513 |
Commitments and contingencies (see note 13) | ||
Stockholders’ equity: | ||
Common stock - $0.01 par value – 20,000,000 shares authorized; issued and outstanding 6,824,511 at December 31, 2023 and 6,760,938 at December 31, 2022 | 68 | 67 |
Additional paid-in capital | 28,695 | 27,712 |
(Accumulated deficit) retained earnings | (2,560) | 1,620 |
Total stockholders’ equity | 26,203 | 29,399 |
Total liabilities and stockholders’ equity | $ 35,025 | $ 37,912 |